CYP2A6 polymorphism reveals differences in Japan and the existence of a specific variant in Ovambo and Turk populations

Human Biology

Volumn 78, Issue 2, 2006, Pages 235-242

  Takeshita, H ^a   Hieda, Y ^a   Fujihara, J ^a   Xue, Y ^a   Nakagami, N ^a   Takayama, K ^a   Imamura, S ^b   Kataoka, K ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b Criminal Investigation Laboratory   (Japan)

Author keywords

CYP2A6 polymorphism; Japanese; Ovambos; Turks

Indexed keywords

CYTOCHROME P450 2A6; CYTOCHROME P450 2A6 1A; CYTOCHROME P450 2A6 1B; CYTOCHROME P450 2A6 1F; CYTOCHROME P450 2A6 1G; CYTOCHROME P450 2A6 4A; CYTOCHROME P450 2A6 4D; ENZYME VARIANT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENE DELETION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HOMOZYGOSITY; HUMAN; JAPAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 33749581218     PISSN: 00187143     EISSN: None     Source Type: Journal    
DOI: 10.1353/hub.2006.0037     Document Type: Article

References (18)

1. Ariyoshi, N., Y. Takahashi, M. Miyamoto et al. 2000. Structural characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. Pharmacogenetics 10:687-693.
2. Cholerton, S., A. Arpanahi, N. McCracken et al. 1994. Poor metabolisers of nicotine and CYP2D6 polymorphism. Lancet 343:62-63.
3. Fujieda, M., H. Yamazaki, T. Saito et al. 2004. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis 25:2451-2458.
4. Gyamli, M. A., M. Fujieda, K. Kiyotami et al. 2005. High prevalence of cytochrome P4502A6*1A alleles in a black African population of Ghana. Eur. J. Clin. Pharmacol. 60:855-857.
5. Hoffman, S. M., D. R. Nelson, and D. S. Keeney. 2001. Organization, structure, and evolution of the CYP2 gene cluster on human chromosome. Pharmacogenetics 11:687-698.
6. Miyamoto, M., Y. Umetsu, H. Dosaka-Akita et al. 1999. CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem. Biophys. Res. Commun. 261:658-660.
7. Nakajima, M., S. I. Yamagishi, H. Yamamoto et al. 2000. Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans. Clin. Pharmacol. Ther. 67:57-69.
8. Nakajima, M., T. Yamamoto, K. Nunoya et al. 1996a. Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsome. J. Pharmacol. Exp. Ther. 277:1010-1015.
9. Nakajima, M., T. Yamamoto, K. Nunoya et al. 1996b. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab. Dispos. 24:1212-1217.
10. Nakajima, M., R. Yoshida, T. Fukami et al. 2004. Novel human CYP2A6 alleles confound gene deletion analysis. FEBS Lett. 569:75-81.
11. Nakanaga, M., T. Yasuda, E. Tenjo et al. 1991. Transferrin polymorphism in Japanese populations: North-south cline in the distribution of the TF*2 allele. Hum. Biol. 63:187-195.
12. Oscarson, M., R. A. MeLellan, H. Gullsten et al. 1999. Identification and characterization of novel polymorphisms in the CYP2A locus: Implications for nicotine metabolism. FEBS Lett. 460:321-327.
13. Pianezza, M. L., E. M. Sellers, and R. F. Tyndale. 1998. Nicotine metabolism defect reduces smoking. Nature 393:750.
14. Rao, Y. K. Hoffman, M. Zia. 2000. Duplications and defects in the CYP2A6 gene: Identification, genotyping, and in vivo effects on smoking. Mol. Pharmacol. 58:747-755.
15. Takeshita, H., S. Mori, T. Yasuda et al. 2000. Japanese population data for two STR loci. HumTPO and HumLPL. Legal Med. 2:64-67.
16. Takeshita, H., T. Yasuda, T. Nakajima et al. 1998. Detection of the two short tandem repeat loci (HumTPO and HumLPL) in Japanese populations using discontinuous polyacrylamide gel electrophoresis. Nippon Honigaku Zasshi 52:139-143.
17. Takeshita, H., T. Yasuda, Y. Nakashima et al. 2001. Geographical north-south decline in DNASE1*2 in Japanese populations. Hum. Biol. 73:129-134.
18. Yoshida, R., M. Nakajima, Y. Watanabe et al. 2002. Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism. Br. J. Clin. Pharmacol. 54:511-517.